{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:29:21Z","timestamp":1793222961404,"version":"4.5.0"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Shanghai Science and Technology Development Funds","award":["22YF1421100"],"award-info":[{"award-number":["22YF1421100"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>COVID-19 pandemic has indirect impacts on patients with chronic medical conditions, which may increase mortality risks for various non-COVID-19 causes. This study updates excess death statistics for Alzheimer\u2019s disease (AD) and Parkinson\u2019s disease (PD) up to 2022 and evaluates their demographic and spatial disparities in the USA.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This is an ecological time-series analysis of AD and PD mortality in the USA from January 2018 to March 2022. Poisson log-linear regressions were utilised to fit the weekly death data. Excess deaths were calculated with the difference between the observed and expected deaths under a counterfactual scenario of pandemic absence.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>From March 2020 to March 2022, we observed 41,115 and 10,328 excess deaths for AD and PD, respectively. The largest percentage increases in excess AD and PD deaths were found in the initial pandemic wave. For people aged \u226585\u00a0years, excess mortalities of AD and PD (per million persons) were 3946.0 (95% confidence interval [CI]: 2954.3, 4892.3) and 624.3 (95% CI: 369.4, 862.5), which were about 23 and 9 times higher than those aged 55\u201384\u00a0years, respectively. Females had a three-time higher excess mortality of AD than males (182.6 vs. 67.7 per million persons). The non-Hispanic Black people experienced larger increases in AD or PD deaths (excess percentage: 31.8% for AD and 34.6% for PD) than the non-Hispanic White population (17.1% for AD and 14.7% for PD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Under the continuing threats of COVID-19, efforts should be made to optimise health care capacity for patients with AD and PD.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ageing\/afac277","type":"journal-article","created":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T16:48:12Z","timestamp":1672073292000},"source":"Crossref","is-referenced-by-count":22,"title":["Excess deaths from Alzheimer\u2019s disease and Parkinson\u2019s disease during the COVID-19 pandemic in the USA"],"prefix":"10.1093","volume":"51","author":[{"given":"Siyuan","family":"Li","sequence":"first","affiliation":[{"name":"Shanghai Jiao Tong University School of Medicine School of Public Health, , Shanghai 200025 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefei","family":"Han","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University School of Medicine School of Global Health, Chinese Center for Tropical Diseases Research, , Shanghai 200025 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoting","family":"Shi","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University School of Medicine School of Clinical Medicine, , Shanghai 200025 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5610-1298","authenticated-orcid":false,"given":"Marc K C","family":"Chong","sequence":"additional","affiliation":[{"name":"Chinese University of Hong Kong JC School of Public Health and Primary Care, , Hong Kong SAR ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Chinese University of Hong Kong JC School of Public Health and Primary Care, , Hong Kong SAR ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2684-6341","authenticated-orcid":false,"given":"Jinjun","family":"Ran","sequence":"additional","affiliation":[{"name":"Shanghai Jiao Tong University School of Medicine School of Public Health, , Shanghai 200025 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"2024103110063685600_ref1","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41591-020-0952-y","article-title":"Disease and healthcare burden of COVID-19 in the United States","volume":"26","author":"Miller","year":"2020","journal-title":"Nat Med"},{"key":"2024103110063685600_ref2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet"},{"key":"2024103110063685600_ref3","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2020.10.055","article-title":"Cardiovascular deaths during the COVID-19 pandemic in the United States","volume":"77","author":"Wadhera","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2024103110063685600_ref4","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.2337\/dc21-0213","article-title":"Increase in diabetes mortality associated with COVID-19 pandemic in the U.S","volume":"44","author":"Ran","year":"2021","journal-title":"Diabetes Care"},{"key":"2024103110063685600_ref5","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1007\/s00415-020-10084-2","article-title":"Excess neurological death in New York City after the emergence of COVID-19","volume":"268","author":"Havenon","year":"2021","journal-title":"J Neurol"},{"key":"2024103110063685600_ref6","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jama.2022.4507","article-title":"Even mild COVID-19 may change the brain","volume":"327","author":"Abbasi","year":"2022","journal-title":"JAMA"},{"key":"2024103110063685600_ref7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamaneurol.2022.0010","article-title":"Trends in mortality rates among medicare enrollees with Alzheimer disease and related dementias before and during the early phase of the COVID-19 pandemic","volume":"79","author":"Gilstrap","year":"2022","journal-title":"JAMA Neurol"},{"key":"2024103110063685600_ref8","volume-title":"National Center for Health Statistics Mortality Data on CDC WONDER","author":"Centers for Disease Control and Prevention","year":"2022"},{"key":"2024103110063685600_ref9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.15585\/mmwr.mm6912e2","article-title":"Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020","volume":"69","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2024103110063685600_ref10","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101205","article-title":"Aging in COVID-19: vulnerability, immunity and intervention","volume":"65","author":"Chen","year":"2021","journal-title":"Ageing Res Rev"},{"key":"2024103110063685600_ref11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.7326\/M21-2134","article-title":"Racial and ethnic disparities in excess deaths during the COVID-19 pandemic, March to December 2020","volume":"174","author":"Shiels","year":"2021","journal-title":"Ann Intern Med"},{"key":"2024103110063685600_ref12","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.15585\/mmwr.mm6933e1","article-title":"Disparities in incidence of COVID-19 among underrepresented racial\/ethnic groups in counties identified as hotspots during June 5-18, 2020-22 states, February-June 2020","volume":"69","author":"Moore","year":"2020","journal-title":"MMWR-Morb Mortal Wkly Rep"},{"key":"2024103110063685600_ref13","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.3233\/JPD-202249","article-title":"The effect of the COVID-19 pandemic on people with Parkinson's disease","volume":"10","author":"Brown","year":"2020","journal-title":"J Parkinsons Dis"},{"key":"2024103110063685600_ref14","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/alz.12143","article-title":"Tackling challenges in care of Alzheimer's disease and other dementias amid the COVID-19 pandemic, now and in the future","volume":"16","author":"Mok","year":"2020","journal-title":"Alzheimers Dement"},{"key":"2024103110063685600_ref15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.28293","article-title":"The impact of COVID-19 on access to Parkinson's disease medication","volume":"35","author":"Cheong","year":"2020","journal-title":"Mov Disord Official J Mov Disord"},{"key":"2024103110063685600_ref16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.parkreldis.2021.10.011","article-title":"North American survey on impact of the COVID-19 pandemic shutdown on DBS care","volume":"92","author":"Siddiqui","year":"2021","journal-title":"Parkinsonism Relat Disord"},{"key":"2024103110063685600_ref17","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jama.2020.11787","article-title":"Excess deaths from COVID-19 and other causes, March-April 2020","volume":"324","author":"Woolf","year":"2020","journal-title":"JAMA J Am Med Assoc"},{"key":"2024103110063685600_ref18","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1007\/s00415-021-10721-4","article-title":"Covid-19 and Parkinson's disease: an overview","volume":"268","author":"Cartella","year":"2021","journal-title":"J Neurol"},{"key":"2024103110063685600_ref19","first-page":"6","article-title":"Early impact of the COVID-19 pandemic on outpatient neurologic care in Hawai'i","volume":"81","author":"Crocker","year":"2022","journal-title":"Hawaii J Health Soc Welf"},{"key":"2024103110063685600_ref20","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ageing\/afaa255","article-title":"Life in lockdown: a telephone survey to investigate the impact of COVID-19 lockdown measures on the lives of older people (\u226575 years)","volume":"50","author":"Brown","year":"2021","journal-title":"Age Ageing"},{"key":"2024103110063685600_ref21","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/alz.12255","article-title":"The chronic neuropsychiatric sequelae of COVID-19: the need for a prospective study of viral impact on brain functioning","volume":"17","author":"Erausquin","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2024103110063685600_ref22","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/alz.12328","article-title":"2021 Alzheimer's disease facts and figures","volume":"17","year":"2021","journal-title":"Alzheimers Dement"},{"key":"2024103110063685600_ref23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41586-022-04569-5","article-title":"SARS-CoV-2 is associated with changes in brain structure in UK Biobank","volume":"604","author":"Douaud","year":"2022","journal-title":"Nature"},{"key":"2024103110063685600_ref24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jamaneurol.2022.0461","article-title":"One-year trajectory of cognitive changes in older survivors of COVID-19 in Wuhan, China: a longitudinal cohort study","volume":"79","author":"Liu","year":"2022","journal-title":"JAMA Neurol"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/51\/12\/afac277\/60264694\/afac277.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/51\/12\/afac277\/60264694\/afac277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:50:18Z","timestamp":1730371818000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afac277\/6936401"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12,5]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afac277","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,12]]},"published":{"date-parts":[[2022,12]]},"article-number":"afac277"}}